Trigeminal Neuralgia
📧 Sign up to get email alerts when something new happens for Trigeminal Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-04-13FDA Approved: CARBAMAZEPINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' Original Application for carbamazepine (generic) under ANDA213311.
-
FDA approval · 2020-04-24FDA Approved: CARBAMAZEPINE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma's original application for carbamazepine, a generic anticonvulsant used to treat epilepsy, trigeminal neuralg…
-
FDA approval · 2020-04-15FDA Approved: CARBAMAZEPINE — Original Application (NIVAGEN PHARMACEUTICALS, INC.)
The FDA approved the original application for a generic carbamazepine product from NIVAGEN PHARMACEUTICALS, INC., marking the approval of th…
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for carbamazepine, allowing an additional product authorizat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-27FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for EPITOL (carbamazepine). This approval pertains to a supplemental filing for the product…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia [Phase 2]
Phase 2 clinical trial assessing the efficacy and tolerability of erenumab for trigeminal neuralgia is reported as ongoing with unknown stat…
-
CLINICAL_TRIALS withdrawal · 2019-11-01Clinical Trial Update: Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia [Phase 4]
A Phase 4 trial evaluating Oxtellar Extended Release (oxcarbazepine extended release) for trigeminal neuralgia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. [Phase 1, Phase 2]
Clinical trial updates safety issues for botulinum toxin type A block of the sphenopalatine ganglion in trigeminal neuralgia, presented as P…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. [Phase 1]
Phase 1 clinical trial evaluating motor cortex stimulation for chronic facial, upper-extremity, and throat pain was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Prognosis of Trigeminal Neuralgia When Enrolled in a Multidisciplinary Management Program
A completed clinical trial evaluating the prognosis of trigeminal neuralgia for patients enrolled in a multidisciplinary management program.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia [Phase 2]
Phase IIa withdrawal study of CNV1014802 in trigeminal neuralgia completed.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: Botulinum Toxin for Trigeminal Neuralgia [Phase 3]
Phase 3 clinical trial update for botulinum toxin in trigeminal neuralgia.
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: 3D-CT-guided Percutaneous Radiofrequency Thermocoagulation for Tumor-related Trigeminal Neuralgia
The clinical trial NCT03549013 evaluating 3D-CT-guided percutaneous radiofrequency thermocoagulation for tumor-related trigeminal neuralgia …
-
CLINICAL_TRIALS research · 2018-05-15Clinical Trial Update: Postoperative Analgesia in Patients With Microvascular Decompression [Phase 4]
Phase 4 clinical trial update evaluating postoperative analgesia for trigeminal neuralgia patients undergoing microvascular decompression; s…
-
FDA approval · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) from Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation, updating the labelin…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia [Phase 2]
Phase 2 trial of intranasal carbon dioxide for symptomatic treatment of classical trigeminal neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Somatosensory Investigation of Orofacial Pain Patients
A completed clinical trial update examining somatosensory aspects in patients with orofacial pain, including trigeminal neuralgia.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers [Phase 1]
Biogen conducted a Phase 1 pharmacokinetics and tolerability study of CNV1014802 in young and elderly healthy volunteers. Trigeminal neuralg…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia [Phase 3]
A Phase 3 study evaluating amifostine to prevent facial numbness after radiosurgery for trigeminal neuralgia was terminated. Results were po…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants [Phase 1]
A Phase 1 pharmacokinetic and safety study of BIIB074 in healthy Japanese and Caucasian participants has completed.
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Regional-anaesthesiological Infiltration Techniques for the Management of Chronic Pain: a Retrospective Study
A retrospective study update evaluating regional anaesthesiological infiltration techniques for managing chronic pain, including trigeminal …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: New Formulation and Food Effect Study of BIIB074 [Phase 1]
Biogen conducted a Phase 1 study evaluating a new formulation of BIIB074 and the effect of food on its pharmacokinetics. The trial has compl…
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc., resulting in changes to the …